[HTML][HTML] A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced …

S Taheri, M Mortazavi, A Pourmoghadas… - Saudi Journal of …, 2012 - journals.lww.com
Congestive heart failure (CHF) is frequent in patients with chronic renal failure, and may
contribute to high cardiovascular morbidity and mortality. There is little data in the literature
about the safety and efficacy of use of spironolactone in patients with end-stage renal
disease with heart failure. In this study, we evaluated the safety and efficacy of
spironolactone in patients on continuous ambulatory peritoneal dialysis (CAPD) with CHF.
This randomized prospective double-blind placebo-controlled clinical trial was performed at …